An evaluation of the early effects of a combination antiretroviral therapy programme on the management of AIDS-associated Kaposi's sarcoma in KwaZulu-Natal, South Africa

International Journal of STD and AIDS

Volumn 22, Issue 11, 2011, Pages 671-673

  Mosam, A ^a   Uldrick, T S ^b   Shaik, F ^a,b   Carrara, H ^a   Aboobaker, J ^a   Coovadia, H ^c  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Antiretroviral therapy; cART; HIV; Kaposi's sarcoma; KS; Outcome; South Africa

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOUTH AFRICA; WORLD HEALTH ORGANIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD, PRESCHOOL; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; SARCOMA, KAPOSI; SOUTH AFRICA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 81355132884     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009145     Document Type: Article

References (12)

1. Dorrington R, Johnson L, Bradshaw D, Daniel T. The Demographic Impact of HIV/AIDS in South Africa. National and Provincial Indicators for 2006. Cape Town: Centre for Actuarial Research, South African Medical Research Counsel, and Actuarial Society of South Africa, 2006
2. Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 2000;82:1585-92
3. Mosam A, Carrara H, Shaik F, et al. Increasing Incidence of Kaposi's Sarcoma in Black South Africans in KwaZulu-Natal, South Africa (1983 to 2006). Int J STD AIDS 2009;20:553-56
4. Stein ME, Spencer D, Kantor A, et al. Epidemic AIDS-related Kaposi's sarcoma in southern Africa: experience at the Johannesburg General Hospital (1980-1990). Trans R Soc Trop Med Hyg 1994;88:434-36
5. Stein ME, Lachter J, Spencer D, Bezwoda WR. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa. Int J Dermatol 1995;34:729-32
6. Stein ME, Lachter J, Spencer D, et al. Variants of Kaposi's sarcoma in Southern Africa. A retrospective analysis (1980-1992). Acta Oncol 1996;35:193-99
7. Olweny CL, Borok M, Gudza I, et al. Treatment of AIDS-associated Kaposi's sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial. Int J Cancer 2005;113:632-39
8. Sitas F, Parkin DM, Chirenje M, et al. Part II: Cancer in Indigenous Africans - causes and control. Lancet Oncol 2008;9:786-95
9. Mohammed AZ, Nwana EJ, Manasseh AN. Changing patterns of Kaposi's sarcoma in Nigerians. Trop Doct 2005;35:168-69
10. Onunu AN, Okoduwa C, Eze EU, et al. Kaposi's sarcoma in Nigeria. Int J Dermatol 2007;46:264-67
11. Pitche PT, Kombate K, Owono F, Tchangai-Walla K. Kaposi's sarcoma in a hospital setting in Lome (Togo): a study of 93 cases. Int J Dermatol 2007;46(Suppl 1):42-44
12. See http://www.tac.org.za/community/keystatistics (last accessed 12 October 2011)